A Study Comparing Two Formulations of Insulin Glargine in Healthy Participants
NCT02955953
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
127
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
LY2963016
Sponsor
Eli Lilly and Company